Skip to main content
OpenTrials

Clinical trial condition

Neoplasms, Plasma Cell

Explore clinical trials studying Neoplasms, Plasma Cell. Study availability and eligibility vary by location and protocol.

2,599 public trials 548 recruiting studies
Refine in advanced search Browse all conditions

Neoplasms, Plasma Cell trial results

Active, Not Recruiting

Daratumumab, Pomalidomide, and Dexamethasone (DPd) in Relapsed/Refractory Light Chain Amyloidosis Patients Previously Exposed to Daratumumab

NCT04270175

Conditions
AL Amyloidosis, Alzheimer Disease, Amyloid, +21 more
Locations
  • Stanford University Palo Alto, California, United States
  • Boston University Medical Center Boston, Massachusetts, United States
  • Weill Cornell Medicine - Multiple Myeloma Center New York, United States
  • Medical College of Wisconsin Milwaukee, Wisconsin, United States
View Trial Details
Active, Not Recruiting

SELIBORDARA: Selinexor, Bortezomib and Daratumumab in Multiple Myeloma

NCT03589222

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • Hospital Germans Trials i Pujol Badalona, Spain
  • Hospital Clinic de Barcelona Barcelona, Spain
  • Hospital ICO de Girona Girona, Spain
  • Hospital ICO de L'hospitalet L'Hospitalet de Llobregat, Spain
View all 15 locations
View Trial Details
Active, Not Recruiting

A Study to Identify Barriers to Cellular Therapies for People With Plasma Cell Disorders

NCT06126341

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Hartford Healthcare Alliance Hartford, Connecticut, United States
  • Memorial Sloan Kettering Basking Ridge Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen Montvale, New Jersey, United States
View Trial Details

Related conditions